Picture EBD Group ChinaBio Partnering Forum 2022 650x100

Person › Details

Stéphane Bancel (Moderna Therapeutics Inc.)

Bancel, Stéphane (Moderna 2011– CEO before bioMérieux 201010 CEO + Eli Lilly)

	Organisation	Moderna Therapeutics Inc.
	Today	Moderna Inc. (Nasdaq: MRNA)
	Group	Moderna (Group)
	Former/major organisation	bioMérieux S.A. (Euronext: BIM)
	Group	Mérieux (Group)
	Product	RNA-based therapeutic
	Product 2	in vitro diagnostics (IVD)

Record changed: 2022-05-02

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Stéphane Bancel

[1] Moderna, Inc.. (4/27/22). "Press Release: Arpa Garay Joins Moderna as Chief Commercial Officer". Cambridge, MA....
[2] Moderna, Inc.. (9/3/21). "Press Release: Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster". Cambridge, MA....
[3] Moderna, Inc.. (6/28/21). "Press Release: Kate Cronin to Join Moderna as Chief Brand Officer on July 12". Cambridge, MA....
[4] Moderna, Inc.. (5/19/21). "Press Release: Moderna to Establish an International Business Services Hub in Warsaw, Poland. Entity Complements Six Commercial Entities in Europe". Cambridge, MA....
[5] Qiagen N.V.. (5/17/21). "Press Release: Qiagen Announces Creation of Scientific Advisory Board and Agenda for Annual General Meeting in June 2021". Venlo....
[6] Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA....
[7] Moderna, Inc.. (1/4/21). "Press Release: Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel". Cambridge, MA....
[8] Moderna, Inc.. (8/24/20). "Press Release: Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)". Cambridge, MA....
[9] Moderna, Inc.. (5/18/20). "Press Release: Moderna Announces Positive Interim Phase 1 Data for Its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus". Cambridge, MA....
[10] Lonza Ltd.. (5/1/20). "Press Release: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) against Novel Coronavirus". Cambridge, MA & Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]